Communicable Diseases Reportable By Law Under Illinois Administrative Code 690.100
Click a disease for a graph of that disease from January through the currently selected month. | Cases for Champaign-Urbana | Cases for Champaign County (Excluding C-U) | Cases for Champaign County (All) | Year to Date
Champaign-Urbana | Year to Date
Champaign County (Excluding C-U) | Year to Date
Champaign County (All) |
| Class I(a) - Reported Immediately |
| Anthrax | 0 | 0 | 0 | 0 | 0 | 0 |
| Any suspected Bioterrorism threat/event | 0 | 0 | 0 | 0 | 0 | 0 |
| Any unusual case or cluster of cases that may indicate a public health hazard | 0 | 0 | 0 | 1 | 0 | 1 |
| Botulism, foodborne | 0 | 0 | 0 | 0 | 0 | 0 |
| Brucellosis (if suspected to be a bioterrorist event or part of an outbreak) included in "Any suspected Bioterrorism threat/event" | 0 | 0 | 0 | 0 | 0 | 0 |
| Diptheria | 0 | 0 | 0 | 0 | 0 | 0 |
| Influenza A, variant | 0 | 0 | 0 | 0 | 0 | 0 |
| Plague | 0 | 0 | 0 | 0 | 0 | 0 |
| Poliomyelitis | 0 | 0 | 0 | 0 | 0 | 0 |
| Q-fever* (if suspected to be a bioterrorist event or part of an outbreak) included in "Any suspected Bioterrorism threat/event" | 0 | 0 | 0 | 0 | 0 | 0 |
| SARS-CoV-2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Severe Acute Repiratiry Syndrome (SARS) | 0 | 0 | 0 | 0 | 0 | 0 |
| Smallpox | 0 | 0 | 0 | 0 | 0 | 0 |
| Class I(b) - Reported within 24 hours |
| Botulism, intestinal, wound, other | 0 | 0 | 0 | 0 | 0 | 0 |
| Brucellosis (24hr, unless bioterrorism suspected then immediate) | 0 | 0 | 0 | 0 | 0 | 0 |
| Chickenpox | 1 | 0 | 1 | 5 | 1 | 6 |
| Cholera | 0 | 0 | 0 | 0 | 0 | 0 |
| Enteric E. coli infections (STEC, O157:H7,ETEC, EPEC, EIEC) | 1 | 0 | 1 | 7 | 2 | 9 |
| Foodborne or waterborne outbreaks | 0 | 0 | 0 | 0 | 0 | 0 |
| Haemophilus influenzae, invasive disease | 0 | 0 | 0 | 0 | 3 | 3 |
| Hantavirus pulmonary syndrome | 0 | 0 | 0 | 0 | 0 | 0 |
| Hemolytic uremic syndrome, post-diarrheal | 0 | 0 | 0 | 0 | 0 | 0 |
| Hepatitis A | 0 | 0 | 0 | 0 | 0 | 0 |
| Influenza, ICU admissions | 0 | 0 | 0 | 1 | 0 | 1 |
| Measles | 0 | 0 | 0 | 0 | 0 | 0 |
| Mumps | 0 | 0 | 0 | 0 | 0 | 0 |
| N. meningitides, invasive | 0 | 0 | 0 | 0 | 0 | 0 |
| Outbreaks of public health significance | 0 | 0 | 0 | 0 | 0 | 0 |
| Pertussis or whooping cough | 0 | 0 | 0 | 0 | 0 | 0 |
| Q-fever (24hr, unless bioterrorism suspected then immediate) | 0 | 0 | 0 | 0 | 0 | 0 |
| Rabies, human | 0 | 0 | 0 | 0 | 0 | 0 |
| Rabies, potential human exposure | 0 | 0 | 0 | 17 | 6 | 23 |
| Rubella | 0 | 0 | 0 | 0 | 0 | 0 |
| Smallpox vaccination, complications of | 0 | 0 | 0 | 0 | 0 | 0 |
| Staphylococcus aureus infections with intermediate or high level resistance to vancomycin* | 0 | 0 | 0 | 0 | 0 | 0 |
| Staphylococcus aureus, Methicillin resistant (MRSA) clusters of 2 or more cases in a community setting | 0 | 0 | 0 | 0 | 0 | 0 |
| Staphylococcus aureus, Methicillin resistant (MRSA), occurring in infants under 61 days of age | 0 | 0 | 0 | 0 | 0 | 0 |
| Streptococcal infections, Group A, invasive including STSS and necrotizing fasciitis | 0 | 0 | 0 | 11 | 7 | 18 |
| Tularemia (24hr unless bioterrorism suspected them immediate) | 0 | 0 | 0 | 0 | 0 | 0 |
| Typhoid fever* | 0 | 0 | 0 | 0 | 0 | 0 |
| Typhus | 0 | 0 | 0 | 0 | 0 | 0 |
| Class II - Reported within 7 days |
| Anaplasmosis | 0 | 0 | 0 | 0 | 0 | 0 |
| Arboviral Infection* (including, but not limited to Zika Virus, California encephalitis, St. Louis encephalitis, West Nile virus Dengue fever, and Chikungunya fever) | 0 | 0 | 0 | 0 | 0 | 0 |
| Babesiosis | 0 | 0 | 0 | 1 | 0 | 1 |
| Campylobacteriosis | 0 | 1 | 1 | 15 | 8 | 23 |
| Chlamydia | 0 | 0 | 0 | 540 | 117 | 657 |
| Creutzfeldt-Jakob Disease | 0 | 0 | 0 | 0 | 0 | 0 |
| Cryptosporidiosis | 0 | 0 | 0 | 4 | 2 | 6 |
| Cyclosporiasis | 0 | 0 | 0 | 1 | 1 | 2 |
| Drug-resistant organism, extensively | 0 | 0 | 0 | 0 | 0 | 0 |
| Early Syphilis (Total number of cases will be updated annually. IDPH defines early syphilis as the stages of Primary, Secondary, and Early, Non-Primary Non-Secondary.) | 0 | 0 | 0 | 0 | 0 | 0 |
| Ehrlichiosis | 0 | 0 | 0 | 0 | 0 | 0 |
| Giardiasis (no longer reportable) | 0 | 0 | 0 | 0 | 0 | 0 |
| Gonorrhea | 0 | 0 | 0 | 197 | 27 | 224 |
| Hepatitis B | 0 | 0 | 0 | 3 | 1 | 4 |
| Hepatitis C* | 0 | 0 | 0 | 6 | 2 | 8 |
| Hepatitis D | 0 | 0 | 0 | 0 | 0 | 0 |
| Histoplasmosis | 0 | 1 | 1 | 2 | 6 | 8 |
| HIV (Total number of cases will be updated annually. | | | 0 | | | 0 |
| Influenza, Deaths in persons less than 18 years of age | 0 | 0 | 0 | 0 | 0 | 0 |
| Legionnaires' disease | 0 | 0 | 0 | 1 | 0 | 1 |
| Leprosy | 0 | 0 | 0 | 0 | 0 | 0 |
| Leptospirosis | 0 | 0 | 0 | 0 | 0 | 0 |
| Listeriosis | 0 | 0 | 0 | 0 | 0 | 0 |
| Lyme disease | 0 | 0 | 0 | 3 | 1 | 4 |
| Malaria | 0 | 0 | 0 | 1 | 0 | 1 |
| Meningitis, Aseptic (no longer reportable) | 0 | 0 | 0 | 0 | 0 | 0 |
| Psittacosis | 0 | 0 | 0 | 0 | 0 | 0 |
| Reye syndrome | 0 | 0 | 0 | 0 | 0 | 0 |
| S. Pneumonia, invasive in those less than 5 years old | 0 | 0 | 0 | 0 | 0 | 0 |
| Salmonellosis* (other than typhoid fever) | 0 | 1 | 1 | 4 | 9 | 13 |
| Shigellosis * | 0 | 0 | 0 | 3 | 0 | 3 |
| Spotted fever rickettsioses | 0 | 0 | 0 | 0 | 0 | 0 |
| Tetanus | 0 | 0 | 0 | 0 | 0 | 0 |
| Tickborne Disease, including ehrlichiosis, anaplasmosis, Lyme disease, and Rocky Mountain spotted fever, see specific disease | 0 | 0 | 0 | 0 | 0 | 0 |
| Toxic Shock syndrome due to S. Aureus | 0 | 0 | 0 | 0 | 0 | 0 |
| Trichinosis | 0 | 0 | 0 | 0 | 0 | 0 |
| Vibriosis (Non-cholera Vibrio infections) | 0 | 0 | 0 | 0 | 0 | 0 |
| Yersiniosis | 0 | 0 | 0 | 0 | 0 | 0 |
